Effects of Chemopreventive Natural Compounds on the Accuracy of 8-oxo-7,8-dihydro-2′-deoxyguanosine Translesion Synthesis^{[ # ]}

Abstract

Translesion synthesis is a DNA damage tolerance mechanism that relies on a series of specialized DNA polymerases able to bypass a lesion on a DNA template strand during replication or post-repair synthesis. Specialized translesion synthesis DNA polymerases pursue replication by inserting a base opposite to this lesion, correctly or incorrectly depending on the lesion nature, involved DNA polymerase(s), sequence context, and still unknown factors. To measure the correct or mutagenic outcome of 8-oxo-7,8-dihydro-2′-deoxyguanosine bypass by translesion synthesis, a primer-extension assay was performed in vitro on a template DNA bearing this lesion in the presence of nuclear proteins extracted from human intestinal epithelial cells (FHs 74 Int cell line); the reaction products were analyzed by both denaturing capillary electrophoresis (to measure the yield of translesion elongation) and pyrosequencing (to determine the identity of the nucleotide inserted in front of the lesion). The influence of 14 natural polyphenols on the correct or mutagenic outcome of translesion synthesis through 8-oxo-7,8-dihydro-2′-deoxyguanosine was then evaluated in 2 experimental conditions by adding the polyphenol either (i) to the reaction mix during the primer extension assay; or (ii) to the culture medium, 24 h before cell harvest and nuclear proteins extraction. Most of the tested polyphenols significantly influenced the outcome of translesion synthesis, either through an error-free (apigenin, baicalein, sakuranetin, and myricetin) or a mutagenic pathway (epicatechin, chalcone, genistein, magnolol, and honokiol).

Key words

translesion synthesis - flavonoids - neolignans - mutation - primer extension assay

^# Dedicated to Professor Arnold Vlietinck on the occasion of his 80th birthday.

Publication History

Received: 26 December 2020

Accepted after revision: 07 June 2021

Article published online:
08 July 2021

• References

• 1 Vineis P, Schatzkin A, Potter JD. Models of carcinogenesis: an overview. Carcinogenesis 2010; 31: 1703-1709
• 2 Poivre M, Nachtergael A, Bunel V, Philippe ON, Duez P. Genotoxicity and Carcinogenicity of herbal Products. In: Pelkonen O, Duez P, Vuorela PM, Vuorela H. eds. Toxicology of herbal Products. Cham: Springer International Publishing; 2017: 179-215
• 3 Balmain A. Cancer genetics: from Boveri and Mendel to microarrays. Nat Rev Cancer 2001; 1: 77-82
• 4 Loeb LA, Springgate CF, Battula N. Errors in DNA replication as a basis of malignant changes. Cancer Res 1974; 34: 2311-2321
• 5 Migheli F, Migliore L. Epigenetic Perturbations in the Context of the multi-hit Hypothesis of Carcinogenesis. In: Maulik N, Karagiannis T. eds. Molecular Mechanisms and Physiology of Disease. New York: Springer; 2014: 383-399
• 6 Link A, Balaguer F, Goel A. Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics. Biochem Pharmacol 2010; 80: 1771-1792
• 7 Schüz J, Espina C, Villain P, Herrero R, Leon ME, Minozzi S, Romieu I, Segnan N, Wardle J, Wiseman M, Belardelli F, Bettcher D, Cavalli F, Galea G, Lenoir G, Martin-Moreno JM, Nicula FA, Olsen JH, Patnick J, Primic-Zakelj M, Puska P, van Leeuwen FE, Wiestler O, Zatonski W, Guha N, Kralikova E, McNeill A, Peruga A, Anderson A, Berrino F, Boutron-Ruault MC, Cecchini M, Key TJ, Leitzmann M, Norat T, Powers HJ, Scoccianti C, Auvinen A, de Vries E, Erdmann F, Greinert R, Harrison J, Kesminiene A, McColl N, Friis S, Kogevinas M, Saracci R, Straif K, Vainio H, Almonte M, Anttila A, De Vuyst H, Dillner J, Franceschi S, Gonzalez P, Hall A, Park JY, Armaroli P, Atkin W, Dean PB, de Koning H, Dillner L, Kuipers E, Lansdorp-Vogelaar I, Paci E, Regula J, Suonio E, Törnberg S, Wood LF, Gaudin N, Frie KG, Terrasse V, Winstanley K, Bellisario C, Biagioli E, Cinquini M, Gianola S, Gonzalez Lorenzo M, von Karsa L, Lignini T. European code against cancer 4th edition: 12 ways to reduce your cancer risk. Cancer Epidemiol 2015; 39: S1-S10
• 8 Wild C, Weiderpass E, Stewart BW. World Cancer Report: Cancer Research for Cancer Prevention. In: Wild C, Weiderpass E, Stewart BW. eds. World Cancer Report. Lyon, France: International Agency for Research on Cancer; 2020: 15-45
• 9 Sporn MB, Dunlop N, Newton D, Smith J. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 1976; 35: 1332-1338
• 10 Theisen C. Chemoprevention: whatʼs in a name?. J Natl Cancer Inst 2001; 93: 743
• 11 Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3: 768-780
• 12 Shukla Y, Pal SK. Dietary cancer chemoprevention: an overview. Int J Hum Genet 2004; 4: 265-276
• 13 De Flora S, Ferguson LR. Overview of mechanisms of cancer chemopreventive agents. Mutat Res Fundam Mol Mech Mutagen 2005; 591: 8-15
• 14 Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, Iigo M, Takasuka N, Moore MA. Cancer prevention by natural compounds. Drug Metab Pharmacokinet 2004; 19: 245-263
• 15 Ramos S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res 2008; 52: 507-526
• 16 Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006; 71: 1397-1421
• 17 Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003; 78: 559S-569S
• 18 La Vecchia C. Mediterranean diet and cancer. Public Health Nutr 2004; 7: 965-968
• 19 Heath AK, Muller DC, van den Brandt PA, Papadimitriou N, Critselis E, Gunter M, Vineis P, Weiderpass E, Fagherazzi G, Boeing H, Ferrari P, Olsen A, Tjønneland A, Arveux P, Boutron-Ruault MC, Mancini FR, Kühn T, Turzanski-Fortner R, Schulze MB, Karakatsani A, Thriskos P, Trichopoulou A, Masala G, Contiero P, Ricceri F, Panico S, Bueno-de-Mesquita B, Bakker MF, van Gils CH, Olsen KS, Skeie G, Lasheras C, Agudo A, Rodríguez-Barranco M, Sánchez MJ, Amiano P, Chirlaque MD, Barricarte A, Drake I, Ericson U, Johansson I, Winkvist A, Key T, Freisling H, His M, Huybrechts I, Christakoudi S, Ellingjord-Dale M, Riboli E, Tsilidis KK, Tzoulaki I. Nutrient-wide association study of 92 foods and nutrients and breast cancer risk. Breast Cancer Res 2020; 22: 5
• 20 Nichols J, Katiyar S. Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms. Arch Dermatol Res 2010; 302: 71-83
• 21 Gullett NP, Ruhul Amin ARM, Bayraktar S, Pezzuto JM, Shin DM, Khuri FR, Aggarwal BB, Surh YJ, Kucuk O. Cancer prevention with natural compounds. Semin Oncol 2010; 37: 258-281
• 22 Shiomi K, Kuriyama I, Yoshida H, Mizushina Y. Inhibitory effects of myricetin on mammalian DNA polymerase, topoisomerase and human cancer cell proliferation. Food Chem 2013; 139: 910-918
• 23 Wu Y, Hsieh TC, Wu JM, Wang X, Christopher JS, Pham AH, Swaby JD, Lou L, Xie ZR. Elucidating the inhibitory effect of resveratrol and its structural analogs on selected nucleotide-related enzymes. Biomolecules 2020; 10: 1223
• 24 McAuley-Hecht KE, Leonard GA, Gibson NJ, Thomson JB, Watson WP, Hunter WN, Brown T. Crystal structure of a DNA duplex containing 8-hydroxydeoxyguanine-adenine base pairs. Biochemistry 1994; 33: 10266-10270
• 25 Arana ME, Kunkel TA. Mutator phenotypes due to DNA replication infidelity. Semin Cancer Biol 2010; 20: 304-311
• 26 Wang D, Kreutzer DA, Essigmann JM. Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions. Mutat Res Fundam Mol Mech Mutagen 1998; 400: 99-115
• 27 Henderson PT, Delaney JC, Gu F, Tannenbaum SR, Essigmann JM. Oxidation of 7,8-dihydro-8-oxoguanine affords lesions that are potent sources of replication errors in vivo . Biochemistry 2001; 41: 914-921
• 28 Henderson PT, Delaney JC, Muller JG, Neeley WL, Tannenbaum SR, Burrows CJ, Essigmann JM. The hydantoin lesions formed from oxidation of 7,8-dihydro-8-oxoguanine are potent sources of replication errors in vivo . Biochemistry 2003; 42: 9257-9262
• 29 Henderson PT, Neeley WL, Delaney JC, Gu F, Niles JC, Hah SS, Tannenbaum SR, Essigmann JM. Urea lesion formation in DNA as a consequence of 7, 8-dihydro-8-oxoguanine oxidation and hydrolysis provides a potent source of point mutations. Chem Res Toxicol 2004; 18: 12-18
• 30 Maki H, Sekiguchi M. MutT protein specifically hydrolyses a potent mutagenic substrate for DNA synthesis. Nature 1992; 355: 273-275
• 31 Radicella JP, Dherin C, Desmaze C, Fox MS, Boiteux S. Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 1997; 94: 8010-8015
• 32 McCann JAB, Berti PJ. Adenine release is fast in MutY-catalyzed hydrolysis of G : A and 8-oxo-G : A DNA mismatches. J Biol Chem 2003; 278: 29587-29592
• 33 Hübscher U, Maga G. DNA replication and repair bypass machines. Curr Opin Chem Biol 2011; 15: 627-635
• 34 Maga G, Villani G, Crespan E, Wimmer U, Ferrari E, Bertocci B, Hubscher U. 8-oxo-guanine bypass by human DNA polymerases in the presence of auxiliary proteins. Nature 2007; 447: 606-608
• 35 Kamiya H, Yamaguchi A, Suzuki T, Harashima H. Roles of specialized DNA polymerases in mutagenesis by 8-hydroxyguanine in human cells. Mutat Res Fundam Mol Mech Mutagen 2010; 686: 90-95
• 36 Irimia A, Eoff RL, Guengerich FP, Egli M. Structural and functional elucidation of the mechanism promoting error-prone synthesis by human DNA polymerase kappa opposite the 7,8-dihydro-8-oxo-2′-deoxyguanosine adduct. J Biol Chem 2009; 284: 22467-22480
• 37 Lee DH, Pfeifer GP. Translesion synthesis of 7,8-dihydro-8-oxo-2′-deoxyguanosine by DNA polymerase eta in vivo . Mutat Res Fundam Mol Mech Mutagen 2008; 641: 19-26
• 38 Rodriguez GP, Song JB, Crouse GF. In vivo bypass of 8-oxodG. PLoS Genet 2013; 9: e1003682
• 39 Tietz D. Nucleic Acid Electrophoresis. Heidelberg: Springer; 1998
• 40 Ding L, Williams K, Ausserer W, Bousse L, Dubrow R. Analysis of plasmid samples on a microchip. Anal Biochem 2003; 316: 92-102
• 41 Nachtergael A, Charles C, Spanoghe M, Gadenne M, Belayew A, Duez P. Measurement of translesion synthesis by fluorescent capillary electrophoresis: 7,8-Dihydro-8-oxodeoxyguanosine bypass modulation by natural products. Anal Biochem 2013; 440: 23-31
• 42 Nachtergael A, Belayew A, Duez P. Pyrosequencing for the quantitative assessment of 8-oxodG bypass DNA synthesis. DNA Repair (Amst) 2014; 22: 147-152
• 43 Charles C, Nachtergael A, Ouedraogo M, Belayew A, Duez P. Effects of chemopreventive natural products on non-homologous end-joining DNA double-strand break repair. Mutat Res Genet Toxicol Environ Mutagen 2014; 768: 33-41
• 44 Shukla S, MacLennan GT, Flask CA, Fu P, Mishra A, Resnick MI, Gupta S. Blockade of β-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice. Cancer Res 2007; 67: 6925-6935
• 45 Liu LZ, Fang J, Zhou Q, Hu X, Shi X, Jiang BH. Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer. Mol Pharmacol 2005; 68: 635-643
• 46 Ono K, Nakane H. Mechanisms of inhibition of various cellular DNA and RNA polymerases by several flavonoids. J Biochem 1990; 108: 609-613
• 47 Fox JT, Sakamuru S, Huang R, Teneva N, Simmons SO, Xia M, Tice RR, Austin CP, Myung K. High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death. Proc Natl Acad Sci U S A 2012; 109: 5423-5428
• 48 Sulfikkarali N, Krishnakumar N, Manoharan S, Nirmal R. Chemopreventive efficacy of naringenin-loaded nanoparticles in 7,12-dimethylbenz(a)anthracene induced experimental oral carcinogenesis. Pathol Oncol Res 2013; 19: 287-296
• 49 Matsubara K, Saito A, Tanaka A, Nakajima N, Akagi R, Mori M, Mizushina Y. Epicatechin conjugated with fatty acid is a potent inhibitor of DNA polymerase and angiogenesis. Life Sci 2007; 80: 1578-1585
• 50 Mizushina Y, Hirota M, Murakami C, Ishidoh T, Kamisuki S, Shimazaki N, Takemura M, Perpelescu M, Suzuki M, Yoshida H, Sugawara F, Koiwai O, Sakaguchi K. Some anti-chronic inflammatory compounds are DNA polymerase λ-specific inhibitors. Biochem Pharmacol 2003; 66: 1935-1944
• 51 Takeuchi T, Ishidoh T, Iijima H, Kuriyama I, Shimazaki N, Koiwai O, Kuramochi K, Kobayashi S, Sugawara F, Sakaguchi K, Yoshida H, Mizushina Y. Structural relationship of curcumin derivatives binding to the BRCT domain of human DNA polymerase λ . Genes Cells 2006; 11: 223-235
• 52 Wu CH, Chen CW, Chen HC, Chang WC, Shu MJ, Hung JS. Elucidating the inhibitory mechanisms of magnolol on rat smooth muscle cell proliferation. J Pharmacol Sci 2005; 99: 392-399
• 53 Vaisman A, Woodgate R. Translesion DNA polymerases in eukaryotes: What makes them tick?. Crit Rev Biochem Mol Biol 2017; 52: 274-303
• 54 Hubscher U, Spadani S, Villani G, Maga G. Structural and functional Aspects of the eukaryotic DNA polymerase families. In: Hubscher U, Spadani S, Villani G, Maga G. eds. DNA Polymerase Discovery, Characterization and Functions in cellular DNA Transactions. Hackensack, NJ: World Scientific; 2010: 111-160
• 55 Murakami A, Ashida H, Terao J. Multitargeted cancer prevention by quercetin. Cancer Lett 2008; 269: 315-325
• 56 Xie K, Doles J, Hemann MT, Walker GC. Error-prone translesion synthesis mediates acquired chemoresistance. Proc Natl Acad Sci U S A 2010; 107: 20792-20797
• 57 Shaheen M, Allen C, Nickoloff JA, Hromas R. Synthetic lethality: exploiting the addiction of cancer to DNA repair. Blood 2011; 117: 6074-6082
• 58 Lange SS, Takata K, Wood RD. DNA polymerases and cancer. Nat Rev Cancer 2011; 11: 96-110
• 59 Doles J, Oliver TG, Cameron ER, Hsu G, Jacks T, Walker GC, Hemann MT. Suppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapy. Proc Natl Acad Sci U S A 2010; 107: 20786-20791